Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 27,010 | 32,138 | 7,517 | 10,912 | 20,033 |
| Receivables | 885 | 1,216 | 3,403 | 3,009 | 1,401 |
| TOTAL | $27,895 | $33,354 | $10,920 | $13,921 | $21,434 |
| Non-Current Assets | |||||
| PPE Net | 393 | 399 | 385 | 347 | 279 |
| Other Non-Current Assets | 2,768 | 3,027 | 1,456 | 935 | 216 |
| TOTAL | $3,161 | $3,426 | $1,841 | $1,282 | $495 |
| Total Assets | $31,056 | $36,780 | $12,761 | $15,203 | $21,929 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,001 | 3,882 | 2,102 | 2,416 | 6,518 |
| Accrued Expenses | 754 | 391 | 644 | 539 | 454 |
| Other current liabilities | N/A | N/A | N/A | 7,005 | 5,598 |
| TOTAL | $3,239 | $4,750 | $2,746 | $9,960 | $12,570 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 2,934 | 5,682 | 210 | 5,010 | 6,699 |
| TOTAL | $2,934 | $5,682 | $210 | $5,010 | $6,699 |
| Total Liabilities | $6,173 | $10,432 | $2,956 | $14,970 | $19,268 |
| Shareholders' Equity | |||||
| Retained earnings | -96,404 | -94,570 | -78,307 | -74,346 | -75,641 |
| Other shareholders' equity | 5,162 | 4,817 | 872 | 4,110 | 3,297 |
| TOTAL | $24,883 | $26,348 | $9,805 | $233 | $2,661 |
| Total Liabilities And Equity | $31,056 | $36,780 | $12,761 | $15,203 | $21,929 |